Your browser doesn't support javascript.
loading
Topiramate is more effective than acetazolamide at lowering intracranial pressure.
Scotton, William J; Botfield, Hannah F; Westgate, Connar Sj; Mitchell, James L; Yiangou, Andreas; Uldall, Maria S; Jensen, Rigmor H; Sinclair, Alex J.
Afiliação
  • Scotton WJ; 1 Metabolic Neurology, Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham, UK.
  • Botfield HF; 2 Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
  • Westgate CS; 3 Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Mitchell JL; 4 Institute of Inflammation and Ageing, University of Birmingham, Edgbaston, Birmingham, UK.
  • Yiangou A; 1 Metabolic Neurology, Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham, UK.
  • Uldall MS; 2 Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
  • Jensen RH; 1 Metabolic Neurology, Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham, UK.
  • Sinclair AJ; 2 Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
Cephalalgia ; 39(2): 209-218, 2019 02.
Article em En | MEDLINE | ID: mdl-29898611

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pressão Intracraniana / Topiramato / Acetazolamida Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pressão Intracraniana / Topiramato / Acetazolamida Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article